For men with benign prostatic hyperplasia (BPH), transurethral Holmium Laser of the Prostate (HoLEP) with Double-n Technology ...

Published in Cell Reports Medicine, results of a VHIO-led study support the feasibility of using RAD51 testing to complement ...

Brain metastases from prostate cancer (PC) seem to be more frequent than in the past, possibly because advances in the treatment of patients with castration-resistant PC have prolonged their survival.

Northwell Staten Island University Hospital has announced the addition of the Focal One High-Intensity Focused Ultrasound ...

In a video interview, William K. Oh, MD, director of precision medicine at Yale Cancer Center and Smilow Cancer Hospital discusses the latest breakthroughs in advanced prostate cancer treatment.

Androgen deprivation is the mainstay of advanced prostate cancer treatment. Despite initial ... Intravenous; mCRPC: Metastatic castration-resistant prostate cancer; P: Placebo; PSA: Prostate ...

Among the overarching trends is earlier and earlier treatment intensification to forestall development of metastases and castration-resistant prostate cancer (CRPC). Triplet therapy with docetaxel ...

Prostate cancer is the second most common cancer affecting men globally, with diagnostic methods and risk assessment ...

Prostate cancer is Australia's most ... This is known as metastasis. Treatment of early disease, when cancer is confined to ...

The study, published in JAMA Network Open, found that nearly half of high-risk prostate cancer patients previously classified as nonmetastatic by conventional imaging actually have metastatic disease ...

Articles were selected for inclusion if they reported on patients with metastatic prostate cancer who received a germline or somatic genomic test and/or made comparisons between those tests, reported ...

performed when metastatic prostate cancer is first diagnosed, can predict which patients are likely to respond to treatment and survive the longest. It can help providers decide which ...